To date, 38 states have enacted requirements for written notifications to women with dense breast tissue – policies of keen relevance to DeepLook’s ability to see through density to reveal the underlying morphology. A recent Boston University Medical School study, published in the Journal of the American College of Radiology, concluded that “one size fits all” notifications have limited impact – and that messages tailored to disparate communities would be more effective. One bright spot: women in notification states were twice as likely to speak with their doctors about breast health.

DeepLook Inc., a Connecticut-based medical software start-up, today obtained U.S. patent protection for innovative medical imaging technology that next year will help launch a suite of new commercial radiology products.